0.89
0.00 (0.00%)
End-of-day quote: 05/24/2024
ADX:JULPHAR
Gulf Pharmaceutical Industries P.S.C. Annual Report
| Year | Year | 2023 | 2022 | 2018 | 2017 | 2016 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
1.64B | 1.62B | 719.80M | 1.15B | 1.45B | 1.39B | 1.36B | |
| GM % | Gross Margin % |
|
33.50% | 30.85% | 21.26% | 45.73% | 60.72% | 58.97% | 60.25% | |
| OM | Operating Margin |
|
-2.30% | -1.77% | -35.75% | 7.91% | 12.68% | 14.67% | 16.44% | |
| EPS | Earnings Per Share |
|
0.00 | -0.07 | -0.02 | -0.94 | 0.14 | 0.32 | 0.37 | 0.37 |
| Div. | Dividends |
|
0.01 | 0.01 | 0.00 | 0.17 | 0.27 | 0.23 | 0.00 | |
| PR % | Payout Ratio % |
|
-14.29% | -50.00% | -0.00% | 121.43% | 84.38% | 62.16% | 0 | |
| Sha. | Shares |
|
1155.23m | 1155.23m | 655.23m | 655.25m | 655.23m | 655.23m | 622.12m | |
| OCF | Operating Cash Flow |
|
92.20M | 19.30M | 178.70M | 81.20M | 267.60M | 39.60M | 108.11M | |
| FCF | Free Cash Flow |
|
-90.50M | -44.40M | 150.80M | -5.10M | 164.50M | -39.58M | 16.45M | |
| FCFS | Free Cash Flow Per Share |
|
0.06 | -0.04 | 0.19 | -0.01 | 0.25 | -0.06 | 0.03 |
